Headline Numbers: UK AI Funding in 2025–26
Dealroom's 2026 UK AI investment report paints a striking picture: UK AI companies raised £8.2bn in 2025, a 64% increase on 2023 levels and a record for any European country in any technology vertical. The UK's share of European AI investment (approximately 38%) has actually increased as UK companies benefited disproportionately from the wave of US capital seeking non-US frontier AI development. The pound's relative stability against the dollar through 2025 also made UK valuations attractive to dollar-denominated funds.
Early-stage investment (Seed and Series A) has accelerated significantly: UK AI Seed rounds averaged £1.8m in 2025, up from £800k in 2022, as investors compete for the best early-stage teams. But the big numbers are driven by late-stage rounds: Wayve's £1.05bn Series C, Stability AI's restructuring capital, and several undisclosed NHS-AI partnership deals contributed disproportionately to the headline total. Median deal sizes across all stages are £4.2m — suggesting a healthy distribution of capital, not just a few giant rounds skewing the average.
Sectors Attracting the Most Investment
Healthcare and life sciences AI accounted for approximately 28% of UK AI investment in 2025 — the largest single sector. UK health AI attracted £2.3bn, including significant venture funding for drug discovery startups (Exscientia, Recursion Pharmaceuticals' UK operations, Relation Therapeutics), clinical workflow AI, and NHS supplier partnerships. The combination of NHS as a world-leading dataset and clinical trial partner, top universities (Oxford, Cambridge, Imperial) and a sympathetic regulatory environment (UKCA device pathway, NICE's AI evaluation framework) makes the UK uniquely competitive.
FinTech AI was the second-largest sector at 22% of investment (£1.8bn). AI enhancements to fraud detection, credit decisioning and algorithmic trading attracted the most capital, followed by RegTech AI (compliance automation for FCA-regulated firms). The UK's global fintech leadership creates a ready domestic market for these products — giving UK AI fintech a distribution advantage over US or European competitors.
Foundation models and AI infrastructure attracted 18% (£1.5bn), including UK compute suppliers, AI safety research labs (multiple recipients of government co-investment), and UK-based training infrastructure providers. Isambard-AI, the UK's national AI supercomputer at University of Bristol, has anchored several commercial partnerships.
Enterprise AI / AI agents (14%, £1.1bn): Autonomous AI agents capable of completing multi-step business processes — booking systems, financial reconciliation, customer journey orchestration — attracted significant investment as the market shifted from LLM curiosity to workflow automation. UK startups competing in this space include Glean's UK operations, several stealth companies, and multiple spinouts from consulting firms.
Climate and sustainability AI (8%, £650m): Using ML for energy grid optimisation, climate modelling, carbon accounting and green materials discovery. Government co-investment (through Innovate UK and the Offshore Wind sector deal) has catalysed this cluster significantly.
Geography: Beyond London
London remains dominant at 68% of UK AI investment, but the share directed at non-London clusters has grown from 18% to 32% since 2021. Cambridge (life sciences and deep tech AI), Edinburgh (NLP, computer vision, financial AI), Manchester (health AI tied to Northumberland NHS systems and Manchester University), and Bristol (robotics, sustainability, AI infrastructure) have all developed genuine critical mass. The government's Investment Zones initiative has accelerated this by co-locating research infrastructure investment with enterprise zone tax reliefs in select regional clusters.
Remote-first funding is also changing the geography: a 2025 analysis of SEIS/EIS investments found that 45% of UK AI startups receiving early-stage investment now have no physical office — founders and investors meeting virtually, with talent distributed across the UK. This democratises access to early-stage capital for founders outside London, though the network effects of the London ecosystem (corporate partnerships, intermediary introductions, Series A follow-on) remain concentrated in the capital.
Who's Investing: Key Active Funds
Balderton Capital — One of the UK's largest and most active venture funds, Balderton has backed Synthesia, Wayve and a dozen other UK AI companies. Managing £3.4bn across multiple funds, it has recently increased its allocation to AI infrastructure and AI agents.
LocalGlobe / Latitude — London-based seed and Series A specialist funds with deep UK AI networks. Known for identifying foundational pre-product teams and backing early; alumni companies include Tractable (insurance AI) and Magic Pony Technology (video AI, acquired by Twitter).
Octopus Ventures — Active across health AI, climate tech AI and enterprise software AI. Notable for its UK-first sourcing focus and its UK-wide portfolio including investments outside London.
US crossover investors — Sequoia, Andreessen Horowitz, Tiger Global and KPCB all have UK AI portfolio companies, primarily via their US funds investing across geographies. Their participation in later-stage rounds (Series B+) has been a significant driver of large deal sizes. Several have opened UK offices in the 2024–26 period.
Middle East sovereign wealth — Mubadala, PIF (Saudi) and ADQ have become significant UK AI investors, attracted by UK government co-investment frameworks and the UK's perceived openness to sovereign investment compared with the US (CFIUS scrutiny) and EU. Their long capital horizons are well-matched to deep tech AI timelines.
Government Co-Investment Programmes
The British Business Bank's AI Growth Capital Fund (£400m committed) has deployed 65% of its capital to date, with a focus on UK AI companies in the scale-up phase (Series B–D). Innovate UK's AI programme (£180m annual budget) focuses on earlier-stage R&D grants and loans. The National Security Strategic Investment Fund (NSSIF) provides classified co-investment in AI with national security applications.
The 2026 Spring Budget announced a new £200m UK AI Champions Programme — designed to back 10–20 UK AI companies with the potential to achieve $10bn+ valuations by 2030. The selection criteria have not been fully disclosed but are understood to prioritise defence AI, healthcare AI and the emerging UK agentic AI cluster. Applications are expected to open in Q3 2026.
Outlook for 2026–27
The UK AI investment environment faces a genuine tension: enormous domestic and international capital appetite competing against a relatively limited pool of high-quality AI teams at the scale-up stage. Seed-stage valuation inflation — driven by US-style FOMO compressed into the UK market — has emerged as a concern among early-stage investors, making disciplined due diligence more important than ever.
The sectors most likely to see investment acceleration in 2026–27 are: AI agents (the transition from LLM to autonomous task completion), UK defence AI (government spending uplift signals strong pipeline), and NHS AI (election commitments to NHS AI investment create pipeline clarity). The key risk to the optimistic outlook is US regulatory uncertainty around cross-border AI data flows — a US move toward data localisation requirements could complicate some of the US-UK cross-investment structures that have powered the recent boom.
